Sarcopenia Market Size, Share, Growth Report 2030

The report covers a forecast and an analysis for the sarcopenia market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the sarcopenia market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the sarcopenia market on a global level.

In order to give the users of this report a comprehensive view of the sarcopenia market, we have included a competitive landscape and an analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, where supplement type, distribution channel, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the sarcopenia market by segmenting the market based on supplement type, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on supplement type, the sarcopenia market is segmented into protein supplement, Vitamin D and Calcium Supplement, and Vitamin B12 supplement. Based on the distribution channel, the sarcopenia market is segmented into hospital pharmacies, retail pharmacies, online pharmacies,  and hypermarket and supermarket.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil. This segment includes the demand for sarcopenia market based on individual segment and treatment in all the regions and countries.

Some of the major players operating in the global sarcopenia market include Abbott Laboratories, Pfizer Inc., Eli Lilly and Company, Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Novartis, Cadila Healthcare, and Amway, among others.

This report segments the global sarcopenia market as follows:

Global Sarcopenia Market: Supplement Type Segment Analysis

• Protein Supplement
• Vitamin D & Calcium Supplement
• Vitamin B12 Supplement

Global Sarcopenia Market: Distribution Channel Segment Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Hypermarket & Supermarket

Global Sarcopenia Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa